ArticleHuman pathology2021

Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.

Ourania Parra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.